Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 10, 2014
Study to evaluate clinical outcomes and economic value of the Vercise™ Deep Brain Stimulation (DBS) System.
-
Apr 7, 2014
The first implant of the S-ICD System performed in Hong Kong.
-
Apr 7, 2014Innovative handle design enables physician preferences for precision, comfort and control when acquiring tissue samples during diagnostic procedures
Boston Scientific Corporation (NYSE: BSX) has received clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval in Europe for the Expect™ Slimline (SL) Needle, which is...
-
Apr 1, 2014These and Other Studies Reinforce Global Commitment to the Development of Innovative Therapies to Improve Care for Patients with Cardiovascular Disease
Reinforcing its position as a global leader in bringing new therapies to patients with heart and cardiovascular disease, Boston Scientific Corporation...
-
Apr 1, 2014
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2014 on...
-
Apr 1, 2014Interim results of the EFFORTLESS registry published in the European Heart Journal
Real-world data on the Boston Scientific Corporation (NYSE:BSX) S-ICD System (Subcutaneous Implantable Defibrillator) are highlighted online this week...
-
Mar 30, 2014
MADIT-CRT long-term follow-up results presented at the American College of Cardiology and published in the New England Journal of Medicine.
-
Mar 27, 2014
Includes late breaking clinical trial assessing use of the Boston Scientific CRT-D therapy in patients with mild heart failure
-
Mar 19, 2014
Recognition is for delivering world class results and demonstrating a strong culture of operational excellence at Maple Grove, Minnesota manufacturing facility.
-
Mar 14, 2014
First implant took place in France, at the Nouvelles Cliniques Nantaises in Nantes.